Table 2.
Expression of Snail according to the clinicopathologic variables in serous adenocarcinomas (n = 61).
| Variables | Snaillow, n (%) | Snailhigh, n (%) | P value |
|---|---|---|---|
| Stage | |||
| I/II | 1 (5.3) | 18 (94.7) | 0.574 |
| III/IV | 4 (9.5) | 38 (90.5) | |
| Grade | |||
| 1 | 0 (0) | 5 (100) | 0.591 |
| 2 | 3 (12) | 22 (88) | |
| 3 | 2 (6.5) | 29 (93.5) | |
| LN metastasis | |||
| No | 4 (9.3) | 39 (90.7) | 0.666 |
| Yes | 1 (5.9) | 16 (94.1) | |
| Responses | |||
| CR/PR | 5 (10.2) | 44 (89.8) | 0.561 |
| SD/PD | 0 (0) | 3 (100) | |
| Platinum sensitivity* | |||
| Sensitive | 4 (12.5) | 28 (87.5) | 0.594 |
| Intermediate | 1 (7.1) | 13 (92.9) | |
| Resistant | 0 (0) | 6 (100) |
LN: lymph node; CR: complete response; PR: partial response; SD: stable disease; PD: progressive disease.
*Platinum sensitivity was defined according to the time interval from the date of last chemotherapy cycle to the first evidence of recurrence; sensitive when the interval was >12 months, intermediate when the interval was >6 months and <12 months, and resistant when the interval was <6 months.